Hillsdale Investment Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-173,870
Closed -$3.06M – 648
2026
Q1
$3.06M Buy
173,870
+17,600
+11% +$353K 0.08% 279
2025
Q4
$3.09M Sell
156,270
-2,000
-1% -$35.9K 0.09% 291
2025
Q3
$2.76M Buy
158,270
+9,570
+6% +$142K 0.08% 292
2025
Q2
$2.08M Buy
148,700
+148,300
+37,075% +$2.39M 0.08% 278
2025
Q1
$7.45K Buy
+400
New +$5.96K ﹤0.01% 502
2023
Q1
– Sell
-243,800
Closed -$2.87M – 555
2022
Q4
$2.87M Sell
243,800
-106,400
-30% -$1.29M 0.24% 140
2022
Q3
$4.15M Buy
+350,200
New +$5.11M 0.37% 99

Other funds holding ALHC

Hillsdale Investment Management's ALHC Position: Q2 2026 in Review

Hillsdale Investment Management sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 173,870 shares — an estimated $3.06M sold.

Hillsdale Investment Management first reported a position in ALHC in Q3 2022 and held it in 7 quarters. The position peaked at $4.15M in Q3 2022. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Hillsdale Investment Management reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 173,870 Alignment Healthcare shares in Q2 2026, an estimated $3.06M.
  • Hillsdale Investment Management first reported a position in Alignment Healthcare in Q3 2022 and held it in 7 quarters.
  • Hillsdale Investment Management's Alignment Healthcare position peaked at $4.15M in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.